All In Biotech

Drug Trial Radar · NCT05731544

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

A Phase 1/2 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, PK, and PD of BMF-219, an Oral Covalent Menin Inhibitor, in Healthy Adults and Adults With T2D

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 443 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

443

Actual

Start

Aug 17, 2022

Primary completion

Nov 18, 2024

Study completion Jul 8, 2025

Sponsor

Lead sponsor
Biomea Fusion Inc.Industry
Sponsor type
Industry
First posted
Feb 16, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Phase 1/ 2 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMF-219, an Oral Covalent Menin Inhibitor, in Healthy Adult Subjects and in Adult Subjects with Type 2 Diabetes Mellitus.

Conditions

  • Type 2 Diabetes Mellitus

Interventions

  • BMF-219Drug

    Investigational Product

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety AssessmentsTime frame: 52 weeks
  2. Pharmacokinetics AssessmentsTime frame: 12 weeks
  3. Change in HbA1cTime frame: 26 weeks

Locations

39 sites in 2 countries. Site status is shown where the registry gives one.

  • Hope Clinical Research

    Canoga Park, California

  • Ark Clinical Research, LLC

    Fountain Valley, California

  • Velocity Clinical Research

    La Mesa, California

  • Ark Clinical Research

    Long Beach, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Metro Clinical Trials

    San Bernardino, California

  • Southwest General Healthcare Center

    Fort Myers, Florida

  • G+C Research Group

    Hialeah, Florida

  • Sunbright Health Research Centers

    Homestead, Florida

  • Avantis Clinical Research

    Miami, Florida

  • Century Research LLC

    Miami, Florida

  • Entrust Clinical Research

    Miami, Florida

  • Panax Clinical Research

    Miami Lakes, Florida

  • David Kavtaradze MD, Inc

    Cordele, Georgia

  • Privia Medical Group

    Savannah, Georgia

  • Cedar Crosse Research Center

    Chicago, Illinois

  • IMA Clinical Research St. Louis

    St Louis, Missouri

  • Santa Rosa Medical Centers of Nevada

    Las Vegas, Nevada

  • Omera Health

    Brooklyn, New York

  • IMA Clinical Research Manhattan

    New York, New York

  • Carolina Research Center

    Shelby, North Carolina

  • Wake Forest Health Network, LLC, Medical Plaza

    Winston-Salem, North Carolina

  • Diabetes and Endocrinology Associates of Stark County

    Canton, Ohio

  • Medical Care, LLC

    Elizabethton, Tennessee

  • IMA Clinical Research

    Austin, Texas

  • Velocity Clinical Research

    Dallas, Texas

  • Zenos Clinical Research

    Dallas, Texas

  • Synergy Groups Medical LLC

    Houston, Texas

  • Synergy Group Medical

    Houston, Texas

  • Synergy Group Medical

    Missouri City, Texas

  • Clinical Trials of Texas, LLC

    San Antonio, Texas

  • Diabetes & Glandular Disease Clinic, P.A.

    San Antonio, Texas

  • Simcare Medical Research

    Sugar Land, Texas

  • Velocity Clinical Research

    Waco, Texas

  • Velocity Clinical Research

    Jordan, Utah

  • Manassas Clinical Research

    Manassas, Virginia

  • BioPharma Services Inc.

    Toronto, Canada

  • BC Diabetes

    Vancouver, British Columbia, Canada

  • Centricity Research LMC

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.